🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
Other Combinations Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 0.15mg (41 products)
Median 0.15mg This product: 20mg
DMAE
25 mg
250 mg
✅ Within RDA (0.5× RDA of 550 mg) 📚 36 studies (Tier A: 1, B: 7)
RDA 550mg This product: 250mg UL 3500mg
100 mg (100% DV)
📊 20.0× RDA — above typical dose 📚 1 studies — no high-quality reviews
RDA 5mg This product: 100mg

Other Ingredients

Maltodextrin Microcrystalline Cellulose Stearic Acid Croscarmellose Sodium

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (94% of products) Nutrient (8% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: 1 tablet 3 times daily or as directed by a health care professional.

Additional Information

Huperzine A enhances memory, focus and concentration by inhibiting the breakdown of the neurotransmitter acetyl-choline.

Product Details

UPC / SKU 6 39793 40309 7
DSLD Entry Date 2012-10-01
Product Type Other Combinations
Form Tablet or Pill
Brand LifeLink
DSLD ID 11844
Data Updated 2026-04-11

Research Evidence

2 Research Sources
64 Avg Quality Score
2 Cochrane Review
B Huperzine A for vascular dementia.
Cochrane Review The Cochrane database of systematic reviews
B Huperzine A for mild cognitive impairment.
Cochrane Review The Cochrane database of systematic reviews
View all evidence for Huperzine A →

Compare Similar Products

View all Huperzine A products →